Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05491850
Other study ID # RIPHAH/FR&AHS/Letter-0985
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2021
Est. completion date December 25, 2021

Study information

Verified date August 2022
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study determines the effects of moderate physical activity on early symptoms of peripheral diabetic neuropathy in type-II diabetes. Most of the literature shows the impact of physical activity to manage/controlling diabetes. Some studies were conducted on animals to study the impact of physical activity on diabetic neuropathy and neurogenesis. There is no study on the impact of physical activity to manage early symptoms of peripheral diabetic neuropathy in patients with type-II diabetes in humans. This study finds the impact of moderate physical activity to manage early symptoms of peripheral diabetic neuropathy in patients with type-II diabetes in humans.


Recruitment information / eligibility

Status Completed
Enrollment 17
Est. completion date December 25, 2021
Est. primary completion date November 30, 2021
Accepts healthy volunteers No
Gender All
Age group 35 Years to 65 Years
Eligibility Inclusion Criteria: - Patients with Type-II Diabetes - Diagnosed cases of Peripheral Diabetic Neuropathy - Peripheral Diabetic Neuropathy Stage 1 & 2 - Numbness or reduced ability to feel pain or temperature changes. - Tingling or burning sensation. - Sharp pains or cramps. - Increased sensitivity to touch - Males and females - Age: 35-65 - HbA1c above 6.5 - Mild activity level on IPAQ-7 (< 150min/per week) - Berg Balance Scale score (< 45) Exclusion Criteria: - Cardiac Issues - Any neurological issue - Lower limb deformity - Acute injury - Hip and Knee OA - Patients with walking difficulty - Diabetic foot

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Moderate Physical Activity for Peripheral Diabetic Neuropathy
Moderate physical activity can increase movement and heart rate are particularly important for people suffering with peripheral neuropathy. Physical activity can improve blood circulation, which strengthens nerve tissues by increasing the flow of oxygen.

Locations

Country Name City State
Pakistan RHS Rehabilitation Center Islamabad Federal

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effect of moderate physical activity on early symptoms of peripheral diabetic neuropathy in type-II diabetes Research Hypothesis 2 Months
See also
  Status Clinical Trial Phase
Recruiting NCT04561609 - Transcutaneous Application of Gaseous CO2 N/A
Not yet recruiting NCT06066944 - Effects of Self-Thai Foot Massage on Pain, Range of Motion and Functional Disability in Type 2 DM N/A
Active, not recruiting NCT06131918 - Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy Phase 2
Completed NCT03113448 - 0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy Phase 3
Completed NCT01293461 - Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes Phase 1/Phase 2